These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 7590628)

  • 1. Hormonal oral contraceptives, urinary porphyrin excretion and porphyrias.
    Gross U; Honcamp M; Daume E; Frank M; Düsterberg B; Doss MO
    Horm Metab Res; 1995 Aug; 27(8):379-83. PubMed ID: 7590628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urinary excretion of porphyrins and their precursors. Longterm observations in acute intermittent porphyrias (author's transl)].
    Brugsch J; Müller H
    MMW Munch Med Wochenschr; 1979 Mar; 121(13):457-8. PubMed ID: 107424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary coproporphyria in Germany: clinical-biochemical studies in 53 patients.
    Kühnel A; Gross U; Doss MO
    Clin Biochem; 2000 Aug; 33(6):465-73. PubMed ID: 11074238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and laboratory findings concerning at first dietary and afterwards cimetidine treatment of acute intermittent porphyria].
    Gullotti D; Schillaci L; Amato S; Salerno L
    Clin Ter; 1994 Aug; 145(8):123-9. PubMed ID: 7955957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of hormonal contraceptives containing 0.05 mg ethinyl estradiol and 0.125 mg desogestrel in normophasic regimen (Oviol)].
    Weijers MJ
    Fortschr Med; 1982 Apr; 100(16):764-7. PubMed ID: 6211403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
    Sobbrio GA; Granata A; D'Arrigo F; Arena D; Panacea A; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):139-41. PubMed ID: 2149912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Porphyria and porphyrinuria].
    Schoenfeld N; Mamet R; Mevasser R; Atsmon A
    Harefuah; 1993 Dec; 125(12):449-52, 496. PubMed ID: 8112676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and serum protein binding of gestodene and 3-keto-desogestrel in women after single oral administration of two different contraceptive formulations.
    Kuhnz W; Schütt B; Power J; Back DJ
    Arzneimittelforschung; 1992 Sep; 42(9):1139-41. PubMed ID: 1445482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of body composition during low-dose estrogen oral contraceptives treatment.
    Franchini M; Caruso C; Nigrelli S; Poggiali C
    Acta Eur Fertil; 1995; 26(2):69-73. PubMed ID: 9098463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemostatic balance during treatment with the newest contraceptives].
    Petersen KR; Skouby SO; Sidelmann J; Jespersen J
    Ugeskr Laeger; 1994 Jan; 156(2):187-90. PubMed ID: 8296409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current developments in hormonal contraception].
    Kuhl H
    Gynakologe; 1992 Aug; 25(4):231-40. PubMed ID: 1398252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
    Palatsi R; Reinilä M; Kivinén S
    Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular, immunological, enzymatic and biochemical studies of coproporphyrinogen oxidase deficiency in a family with hereditary coproporphyria.
    Gross U; Puy H; Kühnel A; Meissauer U; Deybach JC; Jacob K; Martasek P; Nordmann Y; Doss MO
    Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):49-55. PubMed ID: 11929047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of urinary porphyrins and porphyrin precursors in Dutch hospital laboratories: a review of quality control over 5 years.
    Zuijderhoudt FM; Weykamp CW; Willems HL
    Ann Clin Biochem; 2003 Jul; 40(Pt 4):417-8. PubMed ID: 12880545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on patients with polychlorinated biphenyl poisoning. 2. Determination of urinary coproporphyrin, uroporphyrin, delta-aminolevulinic acid and porphobilinogen.
    Chang KJ; Lu FJ; Tung TC; Lee TP
    Res Commun Chem Pathol Pharmacol; 1980 Dec; 30(3):547-54. PubMed ID: 6789414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A large observational clinical evaluation of a desogestrel-containing combiphasic oral contraceptive in Germany.
    Vree ML; Schmidt J
    Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):108-14. PubMed ID: 11518448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.